Physician profile
Brian P Mantor
NPI 1134535081
$3,829.16
in general payments reported to CMS, 2019-2025
8 companies · $137 in 2025
The $137 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,056 · 2020: $412 · 2021: $373 · 2022: $487 · 2023: $596 · 2024: $767 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $914 · Entertainment: $483 · Gift: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.05 |
| Entertainment | $483.48 |
| Gift | $103.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $1,991.11 | 2019-2023 | Nobelactive |
| Keystone Dental INC. | $813.64 | 2022-2024 | |
| Straumann USA LLC | $376.40 | 2019-2025 | |
| Geistlich Pharma, North America, INC. | $337.72 | 2021-2023 | Bio-Materials |
| Biohorizons Implant Systems INC. | $97.21 | 2023-2024 | Biohorizons |
| Implant Direct Sybron International LLC | $85.07 | 2019 | |
| Intersect Ent, INC. | $75.00 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $53.01 | 2019-2025 | Arestin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mantor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.